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Abstract
Background: To assess a pulmonary function change over time the mass flow sensor and the pneumotachograph
are widely used in commercially available instruments. However, the smallest detectable change for both devices
has never been compared. Therefore, the aim of this study is to determine the smallest detectable change in vital
capacity (VC) and single-breath diffusion parameters measured by mass flow sensor and or pneumotachograph.
Method: In 28 healthy pulmonary function technicians VC, transfer factor for carbon monoxide (DLCO) and
alveolar volume (VA) was repeatedly (10×) measured. The smallest detectable change was calculated by 1.96 x
Standard Error of Measurement ×√2.
Findings: The mean (range) of the smallest detectable change measured by mass flow sensor and
pneumotachograph respectively, were for VC (in Liter): 0.53 (0.46-0.65); 0.25 (0.17-0.36) (p = 0.04), DLCO (in
mmol*kPa-1*min-1): 1.53 (1.26-1.7); 1.18 (0.84-1.39) (p = 0.07), VA (in Liter): 0.66. (0.53-0.82); 0.43 (0.34-0.53) (p = 0.04)
and DLCO/VA (in mmol*kPa-1*min-1*L-1): 0.22 (0.19-0.28); 0.19 (0.14-0.22) (p = 0.79).
Conclusions: Smallest detectable significant change in VC and VA as measured by pneumotachograph are smaller
than by mass flow sensor. Therefore, the pneumotachograph is the preferred instrument to estimate lung volume
change over time in individual patients.
Background
To measure pulmonary function changes over time the
mass flow sensor and the pneumotachograph are widely
used instruments. Due to international equipment
requirements, calibration, validation and measurement
procedures both measurement devices are assumed to
have identical reliability [1,2]. However the smallest
detectable change, which is the smallest significant
change that can be detected between individual mea-
surements, has in neither device, been determined. The
smallest detectable change is a very useful parameter for
clinical practice because it shows which changes in a
single patient can be considered a ‘real’ change. Hence,
pulmonary function instruments with the smallest
detectable change are best suited for evaluating changes
as a result of disease progress or applied therapy.
The aim of this study is to determine the smallest
detectable change of vital capacity (VC) and single-
breath diffusion parameters measured by mass flow sen-
sor and pneumotachograph.
Materials and methods
Study design
A total of 28 (two to six per hospital) healthy, non-smoking
pulmonary function technicians from eight different Dutch
hospitals measured repeatedly (10 times) their VC and sin-
gle-breath diffusion parameters (transfer factor for carbon
monoxide (DLCO) and alveolar volume (VA). Each hospital
had three different pulmonary function apparatus of a sin-
gle type that were used in a random sequence, as part of
the standard biological calibration procedure. In three hos-
pitals, eight persons measured their pulmonary function by
mass flow sensor (Vmax series, Sensor medics, Yorba
Linda, USA). In the other five hospitals, 20 persons mea-
sured their pulmonary function by pneumotachograph
(Masterlab series, Jeager, Wurzburg, Germany). All
measurements were performed within a time frame of six
months between October 2008 and September 2009.
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All pulmonary function tests were performed after a careful
calibration procedure of the instruments according to man-
ufacturer’s instructions. Pulmonary function tests were per-
formed according to ERS guidelines. Briefly, for the VC, the
largest value of at least three technically satisfactory deter-
minations not exceeding the next highest one by more than
150 ml was used [1]. For DLCO measurements, the mean
of at least two technically satisfactory DLCO determinations
(maximal difference ≤10% of highest value) was taken.
Ethical approval and informed consent was not
required because this biological validation study does
not fall under the Dutch law on Human Research
(WMO). This was approved by the Medical Ethics Com-
mittee of the VU University Medical Center.
Statistical analyses
Results were expressed as mean ± standard deviation or
range. Unpaired t-test was used to compare pulmonary
function measurement results between laboratories using
a mass flow sensor and a pneumotachograph. Coefficient
of variation was calculated for each pulmonary function
parameter for each individual as the standard deviation
divided by the mean of ten repeated measurements. The
variance components were estimated by two-way analysis
of variation with SPSS (version 15.0) with apparatus and
occasion as random factors, using the restricted maximum
likelihood method. From these variance components, the
standard error of measurement was calculated by taking
the square root of the sum of apparatus, occasion and ran-
dom error variance. (SEM = √(s2 apparatus + s2 occasions
+s2 error)). The smallest detectable change was calculated
as 1.96 × SEM × √2 [3]. Coefficient of variation, standard
error of measurement, different sources of measurement
variation (between apparatuses, occasions, random) and
smallest detectable change differences between the mass
flow sensor and pneumotachograph measurements for all
pulmonary function parameters were checked by Mann
Whitney U test. In all analyses p < 0.05 was considered
significant.
Results
As expected in this healthy study population, the sub-
jects showed absolute pulmonary function results within
the normal physiological range [4,5]. Furthermore, mean
pulmonary function outcome results measured by mass
flow sensor were not different from pneumotachograph
measurements (Table 1).
Figure 1 shows that the coefficient of variation and the
standard error of measurement for VC and all single-
breath diffusion parameters measured by mass flow sensor
were higher than those calculated from the pneumotacho-
graph measurements. However, significance was reached
for VC and VA differences only.
Random error is the major source of error variation in
all pulmonary function results for both measurement
devices, followed by (between) apparatus variation.
Except for DLCO and DLCO/VA measured by mass
flow sensor were the variation due to (between) occa-
sion was slightly higher than between apparatus varia-
tion (Figure 2).
Smallest detectable change
Smallest detectable change for all pulmonary function
parameters measured by pneumotachograph were lower
compared to the mass flow sensor measurements. As was
the case with the standard error of measurement, statistical
significance was reached for VC and VA only (Table 2).
Conclusions and Discussion
In this multi-centre study we found that in a realistic
clinical setting the smallest detectable change for the
volume measurements, VC and VA, was smaller when
measured by pneumotachograph than by mass flow sen-
sor. A similar result was found for the smallest detect-
able difference for DLCO, but did not reached statistical
significance.
These differences were mainly due to a lower mea-
surement error (lower variance, Figure 2) of the pneu-
motachograph measurements. The measurement error
in this study was reflected in absolute values by the
standard error of measurement as well as the coefficient
of variation. The coefficient of variation values in this
study were similar to the values found in long term
repeatability measurements in healthy subjects reported
by Pennock et al. [6] and Jensen et al. [7] These studies
showed that the measurement error of the simple VC
assessment was smaller than the measurement error of
the much more comprehensive single breath diffusion
measurement. Our study confirmed these findings.
Although reliability of pulmonary function tests
is commonly estimated by the coefficient of variation
Hankinson et al. recommend expressing pulmonary
Table 1 Pulmonary function results on three different
pulmonary function instruments
MF PT p
Number of hospitals 3 5
Number of subjects 8 20
VC (L.) 5.0 (0.7) 4.7 (1.2) 0.47
DLCO (mmol/kPa/min) 9.9 (2.3) 9.0 (2.4) 0.41
VA (L.) 6.4 (1.0) 5.8 (1.4) 0.29
DLCO/VA (mmol/kPa/min/L.) 1.5 (0.3) 1.6 (0.2) 0.81
Results are expressed as mean and standard deviation. Mass flow sensor (MF);
pneumotachograph (PT); VC: vital capacity; DLCO: transfer factor for carbon
monoxide; VA: alveolar volume.
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function test variability in absolute terms [8]. The coeffi-
cient of variation provides information about the measure-
ment error related to the mean value of a sample of
repeated measurements over time. This mean value of one
individual patient is usually not known, as in clinical
practice usually one single measurement for an individual
is available. For that reason the smallest detectable change,
which is important for clinical decision making, cannot be
estimated by the coefficient of variation. Nonetheless,
from our study it can be seen that a coefficient of variation
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Figure 1 Coefficient of variation (CV, left) and standard error of measurement (SEM, right) of vital capacity (VC), transfer factor for
carbon monoxide (DLCO), alveolar volume (VA) and DLCO/VA. Each dot represents one hospital. MF is mass flow sensor; PT is
pneumotachograph.
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difference for VC of 1.6 percent between the measurent
devices (Figure 1) doubles smallest detectable change from
0.25L to 0.53L (table 2). This means for clinical practice
that a difference between two consecutive VC measure-
ments in time smaller than 250 ml measured by
pneumotachgraph and smaller than 530 ml when mea-
sured by a mass flow sensor can not be distinguished from
measurement error.
An additional important advantage of the standard error
of measurement (Figure 2) is the possibility to analyze dif-
ferent sources of error variance (between-apparatus,
between occasion and random). This knowledge provides
direct information of the main cause of error. Quality con-
trol management of a pulmonary function laboratory
should, when possible, act on this knowledge [9]. In case
of a large between-apparatus variation one should investi-
gate and solve the cause of this undesirable systematic dif-
ference. Our results show that for all pulmonary function
parameters random variation is the main source of error
for both measurement devices, with the largest values in
the mass flow sensor. Other errors are relatively small.
Consequently, total measurement variation, which is the
sum of all error sources, for all pulmonary function para-
meters is, except for the DLCO/VA, are higher in the
mass flow compared to the pneumotachograph data. Ran-
dom variation can be due to (subject- biological, coinci-
dence (or circumstance) and unsystematic instrument
error. Since there are no differences in the way the pul-
monary function tests are performed on both devices, we
expect the biological and circumstance variations to be
comparable between both devices. Thus, unsystematic
error differences between the measurement devices seem
to be the most likely explanation for the difference in ran-
dom error between the mass flow sensor and pneumota-
chograph measurements. An increased between apparatus
variation for the VC found in the mass flow sensor mea-
surements suggests a higher systematic difference between
the mass flow sensor compared to the between pneumota-
chograph apparatuses. Increased occasion variation points
to a lower degree of repeatability for VC and DLCO of
mass flow devices, compared to the pneumotachograph
devices. It is unlikely that the differences in measurement
error for the pulmonary function parameters between
mass flow and pneumotachograph measurements are due
to differences in absolute values because mean outcome
results from the three “mass flow sensor” hospitals
were not different from the values measured in the five
“pneumotachograph” hospitals.
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Figure 2 Total error variance (= between apparatus, between
occasion and random variation) for vital capacity (VC), transfer
factor for carbon monoxide (DLCO), alveolar volume and
DLCO/VA measured on three apparatuses. * p < 0.05 for random
variation between mass flow sensor (MF) and pneumotachograph
(PT) measurements.
Table 2 Smallest detectable change measured by mass
flow sensor (MF) or pneumotachograph(PT)
MF PT p
VC (L.) 0.53 (0.46 - 0.65) 0.25 (0.17 - 0.36) 0.04
DLCO (mmol/kPa/min 1.53 (1.26 - 1.70) 1.18 (0.84 -1.39) 0.07
VA (L.) 0.66 (0.53 -0.82) 0.43 (0.34 - 0.53) 0.04
DLCO/VA (mmol/kPa/min/
L.)
0.22 (0.19 - 0.28) 0.19 (0.14 - 0.22) 0.79
Results are expressed as mean and range. Mass flow sensor (MF);
pneumotachograph (PT); VC: vital capacity; DLCO: transfer factor for carbon
monoxide; VA: alveolar volume
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In clinical practice knowledge of the smallest detectable
change in patients would be most informative. Appar-
ently, this knowledge is difficult to obtain because one
needs repeated measurements from long term, excep-
tionally stable, patients. Nonetheless, Pennock et al.
showed a larger coefficient of variation in healthy sub-
jects compared to patients in pulmonary function mea-
surements [6]. Therefore, we speculate that the smallest
detectable difference in patients is at least as large as the
values estimated by the healthy subjects in this study.
In summary our results show that the total measurement
error of one single VC or VA measured by pneumotacho-
graph is lower compared to these measurements obtained
by mass flow sensor. Consequently, the smallest detectable
significant change between individual VC and VA mea-
sured by pneumotachograph are smaller than when mea-
sured by mass flow sensor measurements. Therefore, the
pneumotachograph is the preferred instrument to estimate
lung volume change over time in the individual patient.
Although pneumotach performs better than the mass
flow sensor in terms of smallest detectable difference,
the latter has the advantage that it can be used during
exercise and is probably less influenced by temperature
or pressure.
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